Task: Please answer the following question about the molecule with SMILES CSc1cccc(N(C)C(N)=Nc2cc(SC)ccc2Cl)c1.
Description: Please describe this drug.
Completion: CNS 5161 is a blocker of the NMDA ion channel and has completed Phase IIa proof of concept clinical trials as a novel compound for the treatment of neuropathic pain.
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CSc1cccc(N(C)C(N)=Nc2cc(SC)ccc2Cl)c1
CN(C1=CC(=CC=C1)SC)C(=NC2=C(C=CC(=C2)SC)Cl)N
2-(2-chloro-5-methylsulfanylphenyl)-1-methyl-1-(3-methylsulfanylphenyl)guanidine
Please describe this drug.